These findings correspond to those of earlier studies reporting that the methylation of CDH3 and a related reduction or complete loss of protein expression is associated with increased risk of HCC and also correlates with tumor staging and proliferation [28]. This evidence concerns the gene CDH3 and hepatocellular carcinoma.